Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
6-[2-(1H-indol-6-yl)ethyl]pyridin-2‑amine is a synthetic small molecule featuring a pyridine ring and an indole moiety connected via an ethyl chain[1][3][9]. It is classified as a pyridin‑2‑amine derivative. The compound has attracted interest in medicinal chemistry and pharmacology due to its potential biological activities, particularly as an enzyme inhibitor[1][8]. Computational studies suggest it may act as a potent inhibitor of beta-secretase 1 (BACE1), with nanomolar affinity, indicating possible utility in neurodegenerative disease research such as Alzheimer's disease[8]. However, there are no approved indications or clinical trials reported for this compound to date[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 6-[2-(1H-indol-6-yl)ethyl]pyridin-2-amine.